Snowball Effect

Blackbird is an Australia and New Zealand venture capital firm backing ambitious technology companies from the earliest stages through later growth. It invests across software, deep tech, climate, fintech, health and other technology-led sectors, with portfolio companies including Canva, SafetyCulture, Culture Amp, Zoox and Halter.

Accel-KKR is a leading mid-market software and technology investor, established in 2000 as a joint venture between leading venture investor Accel Partners and leading private equity firm KKR. Accel-KKR brings capital, expertise and a network of relationships to our portfolio companies, enabling them to grow faster and more profitably. Throughout the years, the firm has taken a collaborative approach to working with our management teams so that, together, we can help our companies reach their full potential. Accel-KKR focuses primarily on three types of transactions: buyouts of divisions, subsidiaries and business units from public companies; acquisitions and recapitalizations of closely-held private companies; and going-private transactions of small public companies.

Grok Ventures is the private investing vehicle of Mike Cannon-Brookes, co-founder of Atlassian and one of Australia's most successful technology entrepreneurs. Grok Ventures invests in fast-growing technology-enabled businesses with world-class management teams who are solving big problems. Grok particularly likes food and energy companies. We have private, patient, long-term capital, with the flexibility to participate from early-stage or seed financing through to late stage funding rounds (although we prefer to be involved earlier).

OneVentures is one of Australia's leading venture capital firms, with over $900 million in funds under management. We work with companies to take them to that all important next stage, by actively shaping their future. We apply our years of experience, expertise, operational and executional excellence to accelerate their growth and launch them into global markets. OneVentures invests in biotechnology, life sciences and other technology applications. We look for truly innovative products tackling multi-billion-dollar world problems, from needle-free vaccinations to next-generation learning technologies to virtual communications.

Brandon Capital Partners is a life sciences focused seed and venture capital fund manager. It manages three funds, the largest of which is the Medical Research Collaboration Fund with the Australian Federal Government. Brandon Capital works collaboratively with entrepreneurs to demonstrate the benefit of their technology, thereby creating value for them, their teams and our investors. Brandon Capital was founded in 1999 with its headquarters in Sydney, Australia.

Reinventure exists at the third horizon of growth, focused on creating options in future businesses through venture investment and a strategic relationship with our largest limited partner, Westpac Banking Corporation. With $100m to invest in FinTech and adjacent areas, we are uncovering, investing in and nurturing scalable early businesses that will be the future of the industry.